MEETINGS - Medical Labelling (US) October 1998:
This article was originally published in Clinica
Executive Summary
IBC will hold a meeting on Medical Labelling in Florida on October 22-23. Labelling requirements in the US, the EU, Japan and Canada will be discussed as well as aspects of multilingual labelling; developing alternative language on labels; translation of labelling to meet medical device directive requirements; and a comparative analysis of US and EU approaches. Delegates will hear a case study on how a medical device manufacturer prepared for the CE marking deadline for products sold in Europe. Contact IBC in the US for more details. Tel: +1 508 481 6400. Fax: +1 508 481 7911.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.